IMCRImmunocore Holdings plc

Nasdaq immunocore.com


$ 33.05 $ -0.49 (-1.48 %)    

Thursday, 12-Sep-2024 10:08:29 EDT
QQQ $ 468.72 $ 0.09 (0.02 %)
DIA $ 408.12 $ -1.34 (-0.33 %)
SPY $ 554.24 $ -0.75 (-0.14 %)
TLT $ 100.21 $ -0.16 (-0.16 %)
GLD $ 235.27 $ 0.63 (0.27 %)
$ 32.98
$ 33.54
-- x --
$ 33.31 x 205
$ 33.54 - $ 33.54
$ 32.37 - $ 76.98
271,340
na
1.65B
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-immunocore-hldgs

Cantor Fitzgerald analyst Eric Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Overweight.

 immunocore-cfo-and-head-of-strategy-brian-di-donato-informs-his-plans-to-leave-at-year-end-company-to-initiate-search-for-new-cfo

Di Donato has accepted the role of Chief Executive Officer at a private, early-stage biotech headquartered in San Diego, Califo...

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 oppenheimer-reiterates-outperform-on-immunocore-hldgs-raises-price-target-to-89

Oppenheimer analyst Jeff Jones reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from ...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 immunocore-hldgs-q2-2024-gaap-eps-023-beats-045-estimate-sales-75400m-beat-74580m-estimate

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0....

 jp-morgan-maintains-overweight-on-immunocore-hldgs-lowers-price-target-to-66

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and lowers the price target from $7...

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION